Sharescart Research Club logo ×
Screener Research Buy Unlisted Shares Sell Unlisted Shares Startup Funding New IPO New
CSK 178 (-5.3%)Bharat Bank 11300 (0%)Bira 305 (-6.2%)Capgemini Technology 12000 (-2%)Care Health Insurance 158 (0%)Carrier Airconditioning 515 (-1.9%)CIAL 478 (-0.8%)Elcid Investments 350000 (0%)Fincare Small Finance Bank 260 (0%)Fino Paytech Limited 108 (-6.1%)HDFC Securities 10600 (-1.4%)Hero Fincorp 1375 (-8%)ICEX 4.75 (0%)Lava 38 (-5%)Martin and Harris Lab 950 (0%)Merino Industries 3250 (0%)MSEI 4.75 (-4%)Mohan Meakin 2250 (-1.1%)Motilal Oswal 16 (-5.9%)NCL Buildtek 235 (0%)Otis Elevator 3750 (0%)OYO 40 (-2.4%)Pharmeasy 7.25 (-3.3%)Signify Innovations 1275 (0%)Sterlite Power 530 (-7.8%)Studds 650 (0%)Orbis Financial 525 (-1.9%)NSE India 2150 (-1.1%)Schneider Electric 1450 (0%)Kurlon Ent 450 (0%)Madbow 35 (0%)GKN Driveline 1750 (0%)BOAT 1495 (-2%)Urban Tots 68 (-1.4%)ACS Technologies 42 (-8.7%)Market Simplified 32 (0%)Nayara Energy 1400 (0%)PolicyX 62 (0%)Ring Plus 695 (0%)Lakeshore Hospital 135 (0%)ESDS Software 365 (-2.7%)Electrosteel Steel Ltd 39 (-2.5%)ICL Fincorp 25 (-3.8%)Indian Potash 3400 (-1.4%)Indofil Industries 1325 (0%)Maharashtra Knowledge Corporation MKCL 450 (0%)Maxvalue Credits And Investments 4.95 (-10%)Philips Domestic Appliances 575 (-1.7%)Philips India 950 (0%)Ramaraju Surgical Cotton 285 (0%)Resins and Plastic 575 (0%)Shriram Life Insurance 400 (0%)Silverline Technologies Ltd 12 (0%)VIkram Solar Ltd 395 (-7.1%)Empire Spices and Foods ltd 585 (0%)AB Inbev Sabmiller 600 (0%)Assam Carbon Products 440 (0%)India Carbon ltd 895 (0%)Kannur International Airport 128 (0%)Kurlon Ltd 1025 (0%)AV Thomas 22000 (0%)Bazar India 24 (0%)Tata Capital 775 (-6.1%)Polymatech Electronics Pvt Ltd 74 (-5.1%)SBI Mutual Fund 2750 (0%)Goodluck Defence 318 (0%)AVPL 52 (0%)Inkel Ltd 20 (0%)Matrix Gas and Renewables 38 (-15.6%)RRP S4E Innovation 268 (-1.5%)Quality Enviro 1350 (0%)Greenzo Energy Pvt Ltd 675 (4.7%)Spray Engineering Devices 305 (-6.2%)Honeywell Electrical Devices and Systems 5000 (0%)Veeda Clinical Research Limited 475 (0%)NCDEX 348 (2.4%)Onix Renewable 225 (0%)Swiggy CCPS 574410 (0%)HCIN Network 165 (0%)Apollo Green Energy 118 (-13.2%)Ecosure Pulpmolding 49 (-5.8%)Pace Digitek 215 (0%)Downtown Hospital Ltd 375 (0%)Amol Minechem Ltd 995 (0%)Manjushree Technopack 1025 (0%)KLM Axiva Finvest 18 (0%)Hinduja Leyland Finance 215 (2.4%)IKF Finance 425 (0%)Lords Mark Industries 110 (-12%)Zappfresh 118 (0%)PXIL 565 (-11%)Optivalue Tek Consulting 130 (0%)Incred Holdings 165 (-1.8%)Transline Technologies 178 (3.5%)Bootes Impex Tech Ltd 2100 (-12.5%)Lenskart Solutions Pvt Ltd 300 (-3.8%)Ticker Ltd 35 (-12.5%)Physics Wallah 145 (-3.3%)GFCL EV Product LTD 54 (-10%)Big Basket 1950 (0%)Flysbs Aviation IPO 498 (0%)Cheelizza Pizza India Ltd 100 (42.9%)Kineco Limited 2975 (0.8%)Pine Labs Pvt Ltd 365 (0%)

15 Days Price Change

NCDEX Gets SEBI Nod for Equity Segment: High-Risk, High-Reward Bet for Long-Term Investor

Get Best Deals on Unlisted Shares

Find Investment Ideas


Get Best Deals on Unlisted Shares

NCDEX


Summary

NCDEX, India’s leading agri-commodity exchange, has received SEBI’s nod to enter the equity segment under key conditions. While currently loss-making in its core operations, NCDEX’s expansion plans and monopoly in agri-derivatives position it as a high-risk, high-reward bet for long-term investors.


Overview:

The National Commodity & Derivatives Exchange (NCDEX) is the most competent online commodity exchange available in India whose principal business is agriculture-based derivatives. It was commissioned in 2003, is under regulatory control of SEBI, and offers a venue through which price discovery takes place on a transparent level and risk management of agricultural markets is provided.
The Important Highlights:
🔹 94 to 97 percent agri-commodity derivatives market share.
🔹 Provides futures contracts for various farm products such as chana, guar, soybean, mustard seed, and jeera, among others.
🔹 Incorporated in Mumbai with a national presence in farmer producer organisations (FPO), traders and processors.
🔹 Vital in aiding the agriculture value chain in India and particularly in ensuring that farmers can price better.
🔹 Marketed by the agencies such as LIC, NABARD, NSE, and the banks of the state.

SEBI Clears NCDEX Equity Foray

NCDEX has gotten an in-principle approval by the Securities and Exchange Board of India (SEBI) to start its equity and equity derivatives segment. The acceptance was communicated through a SEBI letter dated 29 July 2025, but the segment is subject to fulfilling some requirements before it can launch.

The Conditions of NCDEX of SEBI

1. Protect the amount of commodity.

NCDEX needs to uphold its volume of activities in commodity trading to maintain its core agri-derivative unit, which constitutes approximately 94 percent of its operation.

2. Be IT Ready

Before the launch of the equity segment, it is necessary that the exchange should have its technology infrastructure in place and fully compliant. These systems include trading, clearing and settlement systems.

3. Kick off With Cash Segment First

SEBI has directed NCDEX to first launch its equity products through the cash segment and not to start by offering derivatives

NCDEX vs MCX: Niche vs Diversified Dominance

To better understand NCDEX's positioning in the commodity derivatives space, it's essential to compare it with its largest peer—Multi Commodity Exchange (MCX). While NCDEX leads the agricultural commodities segment, MCX is the dominant force in non-agri derivatives, holding over 90% market share in that space. This contrast offers valuable context: NCDEX operates in a niche but critical part of India’s commodity ecosystem, whereas MCX caters to a broader range of metals and energy contracts. By comparing the two, investors can gauge NCDEX's growth potential, strategic focus, and how it differentiates itself in a market heavily led by MCX.

NCDEX-MCX FY25: Numbers That Tell the Story

MCX is a company with passive, steady profitability, whilst NCDEX is a turnaround and growth story with more risk.

🔹MCX has a revenue of 1113 Cr, which is approximately 9x the revenue (122 Cr) of NCDEX obtained by virtue of its wider coverage of commodities other than agriculture business.

🔹EBITDA Negative at -83 Cr
This indicates that NCDEX incurs losses in its main activities. It has a higher operating cost (staff, tech, administration, and marketing costs, as well as clearing costs) than operating revenue through commodity trading.

🔹NCDEX reports a positive PAT of ₹236 crore

This is not the result of a business turnaround but extraordinary income as a result of asset sales:

1. Sale of Stake in Power Exchange India Ltd (PXIL): 14,700 lakh (~ 147 Cr) profit.

2. Revaluation gain on retained PXIL share after it stopped being an associate -> 22,890 lakhs (~229 Cr).

3. Disposal of share in National E-Repository Ltd (NeRL) – 14.43 Cr profit.

4. Other smaller exceptional gains.
These nonrecurring gains inflated the net profit even though they had a bad operating performance.

🔹A high P/E of MCX suggests a dividend on reliable, repetitive profits on diversified, high-volume goods trading, meaning investors are prepared to compensate predictability and dominance. While NCDEX at low P/E meaning The profitability in FY25 was pegged on the sale of stakes, and the core business is loss-making.

NCDEX: Betting on Potential, Not Present Profits

In the eyes of the investor, NCDEX at the moment is not about what it currently earns but what it can become. Indeed, the negative EBITDA in FY 25 indicates that the core business is haemorrhaging, but the profits that it reports are mainly one-time sales of stakes – i.e., they are not sustainable.

However, NCDEX is an uncommon monopoly since it holds more or less 97 per cent of the agri-derivatives market in India and the monopoly within a regulated sphere is very difficult to emulate. The support given by heavy companies such as NSE, LIC and NABARD gives an excellent dose of credibility and financial security.

When an investor is looking ahead, it is the diversification strategy that is promising: leaving the seasonal agri-dependencies behind, the company is turning to equities derivatives and weather-linked products, which may generate stable, growing income. Add to this the policy impetus to modernise agri markets and climate risk management, and you have a potentially long-term growth trigger. Nevertheless, this remains a high-risk, high-reward game; you’re essentially betting on NCDEX’s ability to fix its operational inefficiencies and successfully execute its expansion, not on the health of its current financials.

The need to invest today or wait depends on the risk appetite of any individual. The long-term returns of such an investment on this change-driven stage have the potential of being larger than the risks. The act of waiting can also reduce the risk by giving a clearer realization of the success of the new segments, though it may mean the missing of the opening intervals. Since financial objectives differ for investors, investors need to conduct good due diligence according to their own financial objectives. Since NCDEX is an unlisted company, it can be accessed through the private unlisted share market such as Sharescart  and therefore timing and entry would need to be all more strategic.

 

Top Unlisted Companies & InstaBuy Companies

Sell or Purchase Share (Tentative Price)

Fundamental Analysis

Company Industry Stock P/E P/B Company rating MCAP (in Cr.) Current Price
Pharmeasy e-Commerce -1.8 1.8 4659 7.3
Reliance Retail Retailing 141.5 23 698659 1400
Orbis Financial Finance - Investment 45.2 9.3 6391 525

Top Recommendations

Hexaware Technologies

It is a leading global provider of BPO and IT services. Hexaware Technologies Limited provides IT consulting, software development, and business process services.

Unique Features

  • Delisted Company
  • Undervalued Stocks
  • Likely to Grow 2x

API Holdings

Incorporated in 2019, The company operates a consumer healthcare app called PharmEasy that enables the home delivery of pharmaceutical products.

Unique Features

  • Market Leader
  • Available now at 66% discount
  • QIB's invest at Rs.100 per share.

Sterlite Power

Sterlite Power began on 5th May 2015 and is headquartered in Delhi. It is a leading developer & solution provider in integrated power transmission.

Unique Features

  • Likely to grow in 4-5 years
  • Part of Vedanta Group
  • Decent Valuation

Signify Innovation

Incorporated in 2015. Signify is into the manufacturing of electric lights and light fixtures for consumers and professionals.

Unique Features

  • Lighting Industry
  • Part of Philips Group
  • Decent Valuation

Chennai Super Kings

CSK is a subsidiary brand of India Cements. This company is quite popular in India as it known for its cricket team.

Unique Features

  • Most loved IPL Team
  • LIC holds more than 6% Shares
  • One of the best businesses

Elcid Investment

Elcid Investments Limited was incorporated on 3 December 1981 in Mumbai. It is a Non-Banking Finance Company registered with the Reserve Bank of India.

Unique Features

  • NBFC
  • Listed Company
  • Book Value is Rs.6,16,440.

Studds Accessories

STUDDS is a leading manufacturer of motorcycle accessories and helmets. They become the largest helmet manufacturer (two-wheeler) in the world.

Unique Features

  • No.1 Brand of Helmets
  • Having business in 20+ countries
  • Trustworthy Management

Mohan Meakin

Mohan Meakin manufactures alcoholic beverages such as rum, whisky, beer, etc., and non-alcoholic beverages like apple juice, mineral water, etc.

Unique Features

  • Delisted Company
  • Decent Valuation
  • Popular alcoholic (Old Monk)

Orbis Financial

Orbis is recognized as a leading player in the Financial Services Industry, providing Securities Services since 2009 to FDI, Corporate, HNI's.

Unique Features

  • leading player
  • Decent Valuation
  • Excellent growth

Schneider Electric

Schneider Electric President Systems Limited is a designer, manufacturer and supplier of customized enclosure systems for over 30 years.

Unique Features

  • Delisted Company
  • Undervalued Stocks
  • In FY22, 45% growth in Sales

Check Health Insurance Premium

Check Health Insurance Premium

Success Stories

How Your Money Can Grow With Us

ICICI Prudential

Pre IPO Price:
130
IPO Price:
334
Listing Price:
310
Absoulte return 138%

1 Lac Invested in ICICI Prudential pre-ipo turned into 2.3 Lac after listing.

ICICI Lombard

Pre IPO Price:
400
IPO Price:
661
Listing Price:
680
Absoulte return 70%

1 Lac Invested in ICICI Lombard pre-ipo turned into 1.7 Lac after listing.

HDFC Life

Pre IPO Price:
210
IPO Price:
290
Listing Price:
344
Absoulte return 64%

1 Lac Invested in HDFC Life pre-ipo turned into 1.6 Lac after listing.

AU Small Finance Bank

Pre IPO Price:
175
IPO Price:
358
Listing Price:
597
Absoulte return 241%

1 Lac Invested in AU Small Finance Bank pre-ipo turned into 3.4 Lac after listing.

RBL Bank

Pre IPO Price:
60
IPO Price:
225
Listing Price:
301
Absoulte return 402%

1 Lac Invested in RBL Bank pre-ipo turned into 5 Lac after listing.

BSE

Pre IPO Price:
200
IPO Price:
806
Listing Price:
1069
Absoulte return 435%

1 Lac Invested in BSE pre-ipo turned into 5.3 Lac after listing.

CDSL

Pre IPO Price:
60
IPO Price:
150
Listing Price:
261
Absoulte return 335%

1 Lac Invested in CDSL pre-ipo turned into 4.3 Lac after listing.

Nazara Tech

Pre IPO Price:
545
IPO Price:
1101
Listing Price:
1990
Absoulte return 265%

1 Lac Invested in Nazara Tech pre-ipo turned into 3.6 Lac after listing.

Dmart Avenue

Pre IPO Price:
280
IPO Price:
300
Listing Price:
616
Absoulte return 120%

1 Lac Invested in Dmart Avenue pre-ipo turned into 2.2 Lac after listing.

Reliance Retail Ltd

Price in 2019:
450
Current Price:
3250
Absoulte return 622.22%

1 Lac Invested in Reliance Retail Ltd pre-ipo turned into 7.2 Lac.

Tata Technologies

Price in 2019:
1100
Current Price:
6350
Absoulte return 477.27%

1 Lac Invested in Tata Technologies pre-ipo turned into 5.7 Lac.

whatsapp